WebMay 26, 2024 · 8501 Background: Although previous trials demonstrated the efficacy and safety of postoperative cisplatin–based adjuvant chemotherapy for resected NSCLC, no phase III study has so far evaluated Pem/Cis in this population. Methods: Patients with completely resected pathological stage II-IIIA Ns-NSCLC were randomized in a 1:1 ratio … WebThe most common chemotherapy drug combinations used to treat lung cancer include cisplatin as one of the drugs. If you can't have cisplatin because of your health, a …
Pembrolizumab Plus Concurrent Chemoradiation Therapy in …
WebDec 10, 2024 · Patients received induction chemotherapy on day 1 of each 21-day cycle comprising cisplatin (75 mg/m 2 ), pemetrexed (500 mg/m 2 ), and bevacizumab (15 mg/kg). Induction chemotherapy was repeated every 3 weeks for a maximum of four cycles. WebThe staging system for lung cancer has recently been revised through the International Association for Study of Lung Diagnosis and staging Cancer (IASLC). ... Treatment with … daughter i love you
Docetaxel maintenance therapy versus best supportive care after …
WebResults: When the PEP was combined with cisplatin and tested against solid tumor cell lines and the CCRF-CEM leukemia cell line, there was a modest synergistic effect. A … WebApr 17, 2024 · The PACIFIC study [NCT02125461] was a phase 3, randomized, placebo-controlled study of patients with stage III [locally advanced, unresectable non–small cell lung cancer] who did not progress after definitive chemo-radiotherapy and were 18 or older, performance status 1, life expectancy 12 weeks or more, all-comers population, 1 to 42 … WebFeb 23, 2024 · Alimta® (pemetrexed) is an FDA-approved chemotherapy drug. It is approved for pleural mesothelioma and non-small cell lung cancer. For pleural mesothelioma, pemetrexed is used in conjunction with cisplatin. The combination of pemetrexed and cisplatin may extend life expectancy for patients. Read About … bkk christian hospital